{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:31:11Z","timestamp":1771968671239,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Chagas heart disease (CHD) is a dilated cardiomyopathy characterized by malignant ventricular arrhythmias and increased risk of sudden cardiac death (SCD). Much controversy exists concerning the efficacy of implantable cardioverter\u2010defibrillator (ICDs) in CHD because of mixed results observed. We report our long\u2010term experience with ICDs for secondary prevention in CHD, with the specific aim of assessing the results in groups with preserved or depressed global left ventricular function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>111 patients (75 males; 60 \u00b1 12 years) were followed for 1,948 \u00b1 1,275 days after ICD. Time to death was the primary outcome; LVEF \u2264 45% the exposure; and age, gender, and ICD therapy delivery the potential confounders. We used time\u2010to\u2010event methods and Cox proportional models for analysis, censoring observations at time of death or at 5\u2010year follow\u2010up in survivors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy\u2010two percent of the patients presented at least one sustained ventricular arrhythmia requiring appropriate therapy, and only three patients received inappropriate therapy. Death occurred in 50 (45%) patients, with an annual mortality rate of 8.4%, mostly due to refractory heart failure or noncardiac causes. Unadjusted survival rates were significantly distinct between patients with left ventricular ejection fraction (LVEF)\u00a0\u2264\u00a045% (26 deaths), 50.5% (95% confidence interval [CI]: 36.2%\u201363.2%) when compared to patients with LVEF\u00a0&gt;\u00a045% (10 deaths), 77.6% (95% CI: 62.3%\u201387.3%, P\u00a0&lt;\u00a00.01). After adjusting for confounders, low LVEF (hazard ratio [HR]: 5.2, 95% CI: 2.3\u201311.6), age (HR: 1.04, 95% CI: 1.01\u20131.07), and female gender (HR: 3.97, 95% CI: 1.85\u20138.54) were independently associated with the outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ICDs successfully aborted life\u2010threatening arrhythmias in CHD patients. Impaired left ventricular function predicted higher mortality in CHD patients with an ICD for secondary prevention of SCD.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pace.13333","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T13:57:24Z","timestamp":1522072644000},"page":"583-588","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Long\u2010term follow\u2010up of Chagas heart disease patients receiving an implantable cardioverter\u2010defibrillator for secondary prevention"],"prefix":"10.1111","volume":"41","author":[{"given":"Maria Licia Ribeiro Cury","family":"Pav\u00e3o","sequence":"first","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elerson","family":"Arfelli","sequence":"additional","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilson","family":"Scorzoni\u2010Filho","sequence":"additional","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Anis","family":"Rassi","sequence":"additional","affiliation":[{"name":"Anis Rassi Hospital  Goi\u00e2nia Goi\u00e2nia Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio","family":"Pazin\u2010Filho","sequence":"additional","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Brolio","family":"Pav\u00e3o","sequence":"additional","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Antonio","family":"Marin\u2010Neto","sequence":"additional","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-8165","authenticated-orcid":false,"given":"Andr\u00e9","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Ribeir\u00e3o Preto Medical School University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60061-X"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781444309768.ch51"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.05.040"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2007.00954.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2007.01011.x"},{"issue":"2","key":"e_1_2_6_7_1","first-page":"1","article-title":"[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy]","volume":"97","author":"Andrade JP","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.08.027"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00495-1"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.3.457"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608029"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2011005000112"},{"key":"e_1_2_6_13_1","first-page":"788","article-title":"Predictors of mortality in patients with dilated cardiomyopathy: Relevance of Chagas disease as an etiological factor","volume":"63","author":"Pereira Nunes Mdo C","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut422"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eun325"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12342"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.04.053"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut011"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2006.00377.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000145610.64014.E4"},{"key":"e_1_2_6_21_1","first-page":"287","article-title":"Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy","volume":"7","author":"Rossi MA","year":"1991","journal-title":"Canadian J Cardiol"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2000.tb07058.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071098"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2001000100008"},{"key":"e_1_2_6_26_1","first-page":"524","article-title":"Epicardial ablation for ventricular tachycardia in chronic Chagas heart disease","volume":"102","author":"Scanavacca M","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02761922000100001"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpace.13333","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pace.13333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:20:15Z","timestamp":1695500415000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pace.13333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1111\/pace.13333"],"URL":"https:\/\/doi.org\/10.1111\/pace.13333","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"2017-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}